Show all results

Consolidated Statement of Comprehensive Income

11.54 KBEXCEL
€ million Note 2019 2018
Profit after tax   1,324 3,396
Items of other comprehensive income that will not be reclassified to profit or loss in subsequent periods:      
Net defined benefit liability 32    
Changes in remeasurement   -488 -34
Tax effect   100 -7
Changes recognized in equity   -388 -41
Equity instruments      
Fair value adjustments   76 29
Tax effect   -1
Changes recognized in equity   76 29
    -312 -13
Items of other comprehensive income that may be reclassified to profit or loss in subsequent periods:      
Debt instruments      
Fair value adjustments   1
Reclassification to profit or loss  
Tax effect  
Changes recognized in equity   1
Cash flow hedge reserve 39    
Fair value adjustments   -15 -71
Reclassification to profit or loss   -20 52
Reclassification to assets   60
Tax effect   -16 12
Changes recognized in equity   9 -7
Cost of cash flow hedge reserve 39    
Fair value adjustments   11 -47
Reclassification to profit or loss   -8 5
Reclassification to assets   21
Tax effect   -24 10
Changes recognized in equity   -32
Currency translation difference      
Changes taken directly to equity   349 626
Reclassification to profit or loss   -6 -7
Changes recognized in equity   344 619
    353 581
Other comprehensive income   41 568
Comprehensive income   1,365 3,964
thereof: attributable to shareholders of Merck KGaA, Darmstadt, Germany   1,359 3,943
thereof: attributable to non-controlling interests 34 6 22
       
Comprehensive income   1,365 3,964
thereof: from continuing operations   1,337 1,634
thereof: from discontinued operation   28 2,330